Tuberculosis after anti-TNF therapy

被引：0
|
作者：
Ömer Nuri Pamuk
Salim Dönmez
机构：
[1] Trakya University Medical Faculty,Department of Rheumatology
来源：
Clinical Rheumatology | 2009年 / 28卷
关键词：
Tuberculosis; Cervical Cancer; Infliximab; Isoniazid; Scleroderma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：747 / 747
相关论文
共 50 条
  • [31] Late onset tuberculosis infection in patients receiving anti-TNFα therapy
    Mongey, A-B
    Doran, J. P.
    Kleinerova, J.
    Fitzgerald, O.
    McDonnell, T. J.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2014, 107 (01) : 69 - 71
  • [32] PERITONEAL AND PLEURAL TUBERCULOSIS SECONDARY TO ANTI-TNF THERAPY - CASE REPORT
    Barreto, Gabriela Cardoso
    Goncalves Prates de Oliveira, Fabia Mara
    Ximenes, Antonio Carlos
    Cardoso Ferraz, Ana Gabriela
    Naves Silva, Lucas Mike
    Santos, Andreza Moreira
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 73 - 73
  • [33] Mitigating tuberculosis reactivation risk in IBD patients on anti-TNF therapy
    Kumar, Peeyush
    Kedia, Saurabh
    Ahuja, Vineet
    ARAB JOURNAL OF GASTROENTEROLOGY, 2024, 25 (04) : 455 - 456
  • [34] Tuberculosis infection under anti-TNF therapy - should we be looking for it?
    Xavier, S.
    Curdia Goncalves, T.
    Dias de Castro, F.
    Magalhaes, J.
    Moreira, M. J.
    Cotter, J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S263 - S263
  • [35] Anti-TNF therapy and cancer
    Carmona, Loreto
    REUMATOLOGIA CLINICA, 2010, 6 (02): : 102 - 105
  • [36] Tuberculosis infection in inflammatory bowel disease patients after anti-TNF therapy in a high tuberculosis prevalence rate area
    De Castro, M. L.
    Hernandez, V.
    Pineda, J. R.
    Pereira, S.
    Martinez-Cadilla, J.
    Sanroman, L.
    Rodriguez-Prada, I.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S191 - S192
  • [37] DEVELOPMENT OF NEUROLOGICAL COMPLICATIONS AFTER THERAPY WITH ANTI-TNF DRUGS
    Errazquin, N.
    Meneses, C.
    Uriarte, M.
    Egues, C. A.
    Belzunegui, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 466 - 466
  • [38] Biological Therapy for Ulcerative Colitis: What is after Anti-TNF
    Fiorino, Gionata
    Cesarini, Monica
    Danese, Silvio
    CURRENT DRUG TARGETS, 2011, 12 (10) : 1433 - 1439
  • [39] OUTCOMES AND ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF TO ANTI-TNF THERAPY COMPARED WITH SWITCHING FROM ANTI-TNF TO VEDOLIZUMAB THERAPY IN PATIENTS WITH IBD
    Chiorean, Michael V.
    Afzali, Anita
    Zhou, Zhou
    Macaulay, Dendy
    Rizzo, Joanne
    Skup, Martha
    Wang, Anthony
    GASTROENTEROLOGY, 2017, 152 (05) : S591 - S591
  • [40] Anti-TNFα treatment and reactivation of latent tuberculosis
    Jolobe, Oscar Mlungu
    LANCET, 2007, 370 (9581): : 27 - 28
12345